Opio Connect develops automated technology solutions specifically for Opioid Treatment Programs (OTPs) to streamline methadone dose assembly and verification. Their ZING® system rapidly prepares medication doses, while PROOF™ enables remote pharmacist verification across multiple sites. This technology increases operational efficiency, reduces manual labor, and expands compliant medication access for patients.
Funding
$900K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Opioid Treatment Programs (OTPs) face challenges in medication dose preparation, including the risk of human error, repetitive tasks leading to nurse burnout, and staffing shortages. Manual dose preparation is time-consuming and can detract from nurses' ability to focus on direct patient care.
Solution
ZING® is a robotic methadone dose assembly system designed to automate the preparation of medication doses in OTPs. The system uses barcode scanning to ensure accuracy and reduce the risk of errors in medication dispensing. By automating repetitive tasks, ZING® aims to alleviate the burden on nursing staff, improve nurse retention, and enhance patient safety. The system enables real-time and advance dose preparation, providing stability in workflows even during staff absences.
Target Audience
The primary target audience includes Opioid Treatment Programs (OTPs), satellite medication units, and corrections facilities seeking to automate medication dispensing, reduce errors, and improve nursing staff retention.
Features
- Robotic system for automated methadone dose assembly
- Barcode scanning for dose verification and error reduction
- Real-time and advance dose preparation capabilities
- Designed to reduce repetitive stress injuries and burnout among nurses
- Aims to improve patient safety by minimizing medication errors